In nonhuman primates, passive transfer of PAP patient-derived GM-CSF autoantibodies reduced expression of GM-CSF signaling axis components in alveolar macrophages in parallel with development of PAP30. This evidence concerns the gene CSF2 and pulmonary alveolar proteinosis.